Abingworth llp - see note investment history in Chiasma inc

Filed on 2016-03-09 by Abingworth Llp SEC CIK 1397144 Form 4/a

Accession 0000905718-16-001260.txt Sec File: edgar/data/1397144/0000905718-16-001260-index.htm

2015-07-15 Abingworth Llp (CIK 1397144) through See Note

Invested in Chiasma Inc sold 109504 shares remaining shares owned 109504

Warrants Right To Purchase Chiasma Inc Chma item expiration due date 2024-12-16 underlying security shares 109504 underlying security title Common Stock

f5 abingworth has the right to purchase shares of the issuer's common stock under the series e convertible preferred stock purchase agreement at a price of $9.13, which right to purchase is currently exercisable and expires on december 16, 2024.
f3 the shares are held by abingworth bioventures v, lp ("abingworth"). abingworth bioventures v gp lp ("abingworth gp") serves as the general partner of abingworth. abingworth general partner v llp, serves as the general partner of abingworth gp. abingworth (acting by its general partner abingworth gp, acting by its general partner abingworth general partner v llp) has delegated to abingworth llp, all investment and dispositive power over the securities held by abingworth. the reporting person holds the reported securities indirectly through abingworth. the reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. this report shall not be deemed an admission that the reporting person, abingworth or any other person is the beneficial owner of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, or for any other purpose.
f2 reflects a 1-for-9.132 reverse stock split effected on june 30, 2015.


Filed on 2016-03-09 by Abingworth Llp SEC CIK 1397144 Form 4/a

Accession 0000905718-16-001260.txt Sec File: edgar/data/1397144/0000905718-16-001260-index.htm

2015-07-15 Abingworth Llp (CIK 1397144) through See Note

Invested in Chiasma Inc sold 410642 shares remaining shares owned 410642

Warrants Right To Purchase Chiasma Inc Chma underlying security shares 410642 underlying security title Common Stock

f4 abingworth has the right to purchase shares of the issuer's common stock under the series d' convertible preferred stock purchase agreement at a price of $0.09, which right to purchase is currently exercisable and expires with regards to half of the shares on march 28, 2022 and with regards to the other half of the shares on october 22, 2022.
f3 the shares are held by abingworth bioventures v, lp ("abingworth"). abingworth bioventures v gp lp ("abingworth gp") serves as the general partner of abingworth. abingworth general partner v llp, serves as the general partner of abingworth gp. abingworth (acting by its general partner abingworth gp, acting by its general partner abingworth general partner v llp) has delegated to abingworth llp, all investment and dispositive power over the securities held by abingworth. the reporting person holds the reported securities indirectly through abingworth. the reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. this report shall not be deemed an admission that the reporting person, abingworth or any other person is the beneficial owner of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, or for any other purpose.
f2 reflects a 1-for-9.132 reverse stock split effected on june 30, 2015.


Filed on 2016-03-09 by Abingworth Llp SEC CIK 1397144 Form 4/a

Accession 0000905718-16-001260.txt Sec File: edgar/data/1397144/0000905718-16-001260-index.htm

2015-07-15 Abingworth Llp (CIK 1397144) through See Note

Invested in Chiasma Inc sold 438020 shares remaining shares owned 0

Series E Convertible Preferred Stock Chiasma Inc Chma underlying security shares 438020 underlying security title Common Stock

f1 upon the closing of the issuer's initial public offering, each share of series d' convertible preferred stock and series e convertible stock automatically converted into common stock on a 1-for-9.132 (after reverse stock split) basis without payment of further consideration.
f3 the shares are held by abingworth bioventures v, lp ("abingworth"). abingworth bioventures v gp lp ("abingworth gp") serves as the general partner of abingworth. abingworth general partner v llp, serves as the general partner of abingworth gp. abingworth (acting by its general partner abingworth gp, acting by its general partner abingworth general partner v llp) has delegated to abingworth llp, all investment and dispositive power over the securities held by abingworth. the reporting person holds the reported securities indirectly through abingworth. the reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. this report shall not be deemed an admission that the reporting person, abingworth or any other person is the beneficial owner of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, or for any other purpose.
f2 reflects a 1-for-9.132 reverse stock split effected on june 30, 2015.


Filed on 2016-03-09 by Abingworth Llp SEC CIK 1397144 Form 4/a

Accession 0000905718-16-001260.txt Sec File: edgar/data/1397144/0000905718-16-001260-index.htm

2015-07-15 Abingworth Llp (CIK 1397144) through See Note

Invested in Chiasma Inc sold 1642575 shares remaining shares owned 0

Series D Convertible Preferred Stock Chiasma Inc Chma underlying security shares 1642575 underlying security title Common Stock

f1 upon the closing of the issuer's initial public offering, each share of series d' convertible preferred stock and series e convertible stock automatically converted into common stock on a 1-for-9.132 (after reverse stock split) basis without payment of further consideration.
f3 the shares are held by abingworth bioventures v, lp ("abingworth"). abingworth bioventures v gp lp ("abingworth gp") serves as the general partner of abingworth. abingworth general partner v llp, serves as the general partner of abingworth gp. abingworth (acting by its general partner abingworth gp, acting by its general partner abingworth general partner v llp) has delegated to abingworth llp, all investment and dispositive power over the securities held by abingworth. the reporting person holds the reported securities indirectly through abingworth. the reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. this report shall not be deemed an admission that the reporting person, abingworth or any other person is the beneficial owner of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, or for any other purpose.
f2 reflects a 1-for-9.132 reverse stock split effected on june 30, 2015.


Filed on 2016-03-09 by Abingworth Llp SEC CIK 1397144 Form 4/a

Accession 0000905718-16-001260.txt Sec File: edgar/data/1397144/0000905718-16-001260-index.htm

2015-07-15 Abingworth Llp (CIK 1397144) through See Note

Invested in Chiasma Inc bought 2080595 shares remaining shares owned 2080595

Common Stock Chiasma Inc Chma Transaction code: C Conversion of derivative security (usually options)

f1 upon the closing of the issuer's initial public offering, each share of series d' convertible preferred stock and series e convertible stock automatically converted into common stock on a 1-for-9.132 (after reverse stock split) basis without payment of further consideration.
f2 reflects a 1-for-9.132 reverse stock split effected on june 30, 2015.
f3 the shares are held by abingworth bioventures v, lp ("abingworth"). abingworth bioventures v gp lp ("abingworth gp") serves as the general partner of abingworth. abingworth general partner v llp, serves as the general partner of abingworth gp. abingworth (acting by its general partner abingworth gp, acting by its general partner abingworth general partner v llp) has delegated to abingworth llp, all investment and dispositive power over the securities held by abingworth. the reporting person holds the reported securities indirectly through abingworth. the reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. this report shall not be deemed an admission that the reporting person, abingworth or any other person is the beneficial owner of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, or for any other purpose.


Filed on 2015-07-17 by Abingworth Llp SEC CIK 1397144 Form 4

Accession 0000905718-15-000628.txt Sec File: edgar/data/1397144/0000905718-15-000628-index.htm

2015-07-15 Abingworth Llp (CIK 1397144) through See Note

Invested in Chiasma Inc sold 109504 shares remaining shares owned 0

Warrants Right To Purchase Chiasma Inc Chma underlying security shares 109504 underlying security title Common Stock

f5 abingworth had the right to purchase shares of the issuer's common stock under the series e convertible preferred stock purchase agreement at a price of $9.13, which right to purchase ceased to be exercisable upon the closing of the issuer's initial public offering. upon the closing of the issuer's initial public offering, each warrant automatically converted into common stock on a 1-for-9.132 basis (without payment of further consideration and with no expiration date).
f3 the shares are held by abingworth bioventures v, lp ("abingworth"). abingworth bioventures v gp lp ("abingworth gp") serves as the general partner of abingworth. abingworth general partner v llp, serves as the general partner of abingworth gp. abingworth (acting by its general partner abingworth gp, acting by its general partner abingworth general partner v llp) has delegated to abingworth llp, all investment and dispositive power over the securities held by abingworth. the reporting person holds the reported securities indirectly through abingworth. the reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. this report shall not be deemed an admission that the reporting person, abingworth or any other person is the beneficial owner of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, or for any other purpose.
f2 reflects a 1-for-9.132 reverse stock split effected on june 30, 2015.


Filed on 2015-07-17 by Abingworth Llp SEC CIK 1397144 Form 4

Accession 0000905718-15-000628.txt Sec File: edgar/data/1397144/0000905718-15-000628-index.htm

2015-07-15 Abingworth Llp (CIK 1397144) through See Note

Invested in Chiasma Inc sold 410642 shares remaining shares owned 0

Warrants Right To Purchase Chiasma Inc Chma underlying security shares 410642 underlying security title Common Stock

f4 abingworth had the right to purchase shares of the issuer's common stock under the series d' convertible preferred stock purchase agreement at a price of $0.09, which right to purchase ceased to be exercisable upon the closing of the issuer's initial public offering. upon the closing of the issuer's initial public offering, each warrant automatically converted into common stock on a 1-for-9.132 basis (without payment of further consideration and with no expiration date).
f3 the shares are held by abingworth bioventures v, lp ("abingworth"). abingworth bioventures v gp lp ("abingworth gp") serves as the general partner of abingworth. abingworth general partner v llp, serves as the general partner of abingworth gp. abingworth (acting by its general partner abingworth gp, acting by its general partner abingworth general partner v llp) has delegated to abingworth llp, all investment and dispositive power over the securities held by abingworth. the reporting person holds the reported securities indirectly through abingworth. the reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. this report shall not be deemed an admission that the reporting person, abingworth or any other person is the beneficial owner of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, or for any other purpose.
f2 reflects a 1-for-9.132 reverse stock split effected on june 30, 2015.


Filed on 2015-07-17 by Abingworth Llp SEC CIK 1397144 Form 4

Accession 0000905718-15-000628.txt Sec File: edgar/data/1397144/0000905718-15-000628-index.htm

2015-07-15 Abingworth Llp (CIK 1397144) through See Note

Invested in Chiasma Inc sold 438020 shares remaining shares owned 0

Series E Convertible Preferred Stock Chiasma Inc Chma underlying security shares 438020 underlying security title Common Stock

f1 upon the closing of the issuer's initial public offering, each share of series d' convertible preferred stock and series e convertible stock automatically converted into common stock on a 1-for-9.132 (after reverse stock split) basis without payment of further consideration.
f3 the shares are held by abingworth bioventures v, lp ("abingworth"). abingworth bioventures v gp lp ("abingworth gp") serves as the general partner of abingworth. abingworth general partner v llp, serves as the general partner of abingworth gp. abingworth (acting by its general partner abingworth gp, acting by its general partner abingworth general partner v llp) has delegated to abingworth llp, all investment and dispositive power over the securities held by abingworth. the reporting person holds the reported securities indirectly through abingworth. the reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. this report shall not be deemed an admission that the reporting person, abingworth or any other person is the beneficial owner of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, or for any other purpose.
f2 reflects a 1-for-9.132 reverse stock split effected on june 30, 2015.


Filed on 2015-07-17 by Abingworth Llp SEC CIK 1397144 Form 4

Accession 0000905718-15-000628.txt Sec File: edgar/data/1397144/0000905718-15-000628-index.htm

2015-07-15 Abingworth Llp (CIK 1397144) through See Note

Invested in Chiasma Inc sold 1642575 shares remaining shares owned 0

Series D Convertible Preferred Stock Chiasma Inc Chma underlying security shares 1642575 underlying security title Common Stock

f1 upon the closing of the issuer's initial public offering, each share of series d' convertible preferred stock and series e convertible stock automatically converted into common stock on a 1-for-9.132 (after reverse stock split) basis without payment of further consideration.
f3 the shares are held by abingworth bioventures v, lp ("abingworth"). abingworth bioventures v gp lp ("abingworth gp") serves as the general partner of abingworth. abingworth general partner v llp, serves as the general partner of abingworth gp. abingworth (acting by its general partner abingworth gp, acting by its general partner abingworth general partner v llp) has delegated to abingworth llp, all investment and dispositive power over the securities held by abingworth. the reporting person holds the reported securities indirectly through abingworth. the reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. this report shall not be deemed an admission that the reporting person, abingworth or any other person is the beneficial owner of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, or for any other purpose.
f2 reflects a 1-for-9.132 reverse stock split effected on june 30, 2015.


Filed on 2015-07-17 by Abingworth Llp SEC CIK 1397144 Form 4

Accession 0000905718-15-000628.txt Sec File: edgar/data/1397144/0000905718-15-000628-index.htm

2015-07-15 Abingworth Llp (CIK 1397144) through See Note

Invested in Chiasma Inc bought 2600741 shares remaining shares owned 2600741

Common Stock Chiasma Inc Chma Transaction code: C Conversion of derivative security (usually options)

f1 upon the closing of the issuer's initial public offering, each share of series d' convertible preferred stock and series e convertible stock automatically converted into common stock on a 1-for-9.132 (after reverse stock split) basis without payment of further consideration.
f2 reflects a 1-for-9.132 reverse stock split effected on june 30, 2015.
f3 the shares are held by abingworth bioventures v, lp ("abingworth"). abingworth bioventures v gp lp ("abingworth gp") serves as the general partner of abingworth. abingworth general partner v llp, serves as the general partner of abingworth gp. abingworth (acting by its general partner abingworth gp, acting by its general partner abingworth general partner v llp) has delegated to abingworth llp, all investment and dispositive power over the securities held by abingworth. the reporting person holds the reported securities indirectly through abingworth. the reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. this report shall not be deemed an admission that the reporting person, abingworth or any other person is the beneficial owner of the securities reported herein for purposes of section 16 of the securities exchange act of 1934, as amended, or for any other purpose.